Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults
- DOI
- 10.1016/j.vaccine.2025.126744
- Published
- 2025-03
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2025.126744,
title = {Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults},
author = {Yoshikazu Honda-Okubo and Dimitar Sajkov and Bruce Wauchope and Joseph V. Turner and Brendan Vote and Anna Antipov and Greiciely André and Yuri Lebedin and Nikolai Petrovsky},
year = {2025},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2025.126744},
url = {https://doi.org/10.1016/j.vaccine.2025.126744}
}RIS
TY - JOUR TI - Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults AU - Yoshikazu Honda-Okubo AU - Dimitar Sajkov AU - Bruce Wauchope AU - Joseph V. Turner AU - Brendan Vote AU - Anna Antipov AU - Greiciely André AU - Yuri Lebedin AU - Nikolai Petrovsky PY - 2025 JO - Vaccine DO - 10.1016/j.vaccine.2025.126744 UR - https://doi.org/10.1016/j.vaccine.2025.126744 ER -
APA
Honda-Okubo, Y., Sajkov, D., Wauchope, B., Turner, J. V., Vote, B., Antipov, A., André, G., Lebedin, Y., & Petrovsky, N. (2025). Immunogenicity and safety study of a single dose of SpikoGen® vaccine as a heterologous or homologous intramuscular booster following a primary course of mRNA, adenoviral vector or recombinant protein COVID-19 vaccine in ambulatory adults. Vaccine. https://doi.org/10.1016/j.vaccine.2025.126744
Source records
- crossref · retrieved 2026-09-26T21:54:14.994Z